131 related articles for article (PubMed ID: 110929)
1. Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results?
Menard HA; Mathieu JP; de Medicis R; Lussier A
J Rheumatol; 1979; 6(2):156-62. PubMed ID: 110929
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
Halberg P
Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
[No Abstract] [Full Text] [Related]
3. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
Tsvetkova ES
Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
[TBL] [Abstract][Full Text] [Related]
4. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
Weinstein A; Rothfield NF
J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
[TBL] [Abstract][Full Text] [Related]
5. D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factors.
Vlachoyiannopoulos PG; Zerva LV; Skopouli FN; Drosos AA; Moutsopoulos HM
J Rheumatol; 1991 Jan; 18(1):44-9. PubMed ID: 1827158
[TBL] [Abstract][Full Text] [Related]
6. Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome.
Saudan-Kister A; Gabay C; Tiercy JM; Mermillod B; Guerne PA; Vischer TL
Rev Rhum Engl Ed; 1996 May; 63(5):313-20. PubMed ID: 8789876
[TBL] [Abstract][Full Text] [Related]
7. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
[TBL] [Abstract][Full Text] [Related]
8. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
[TBL] [Abstract][Full Text] [Related]
9. Pattern of response to systematised drug therapy in rheumatoid arthritis in Indians.
Malaviya AN; Khan KM; Tiwari SC
Indian J Med Res; 1983 May; 77():686-96. PubMed ID: 6413397
[No Abstract] [Full Text] [Related]
10. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
Wolfe F; Hawley DJ; Cathey MA
J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
[TBL] [Abstract][Full Text] [Related]
11. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
Capell HA; Hunter JA; Rennie JA; Murdoch RM
J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
[TBL] [Abstract][Full Text] [Related]
12. [Chlorbutin, azathioprine, D-penicillamine and levamisole (decaris) in the treatment of patients with rheumatoid arthritis. IV. Comparative evaluation of their effects on systemic (extra-articular) manifestations of the disease].
Krel' AA; Kanevskaia MZ; Chichasova NV; Khamishon LZ; Nemchenov EN
Ter Arkh; 1985; 57(8):44-52. PubMed ID: 3906995
[TBL] [Abstract][Full Text] [Related]
13. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
Flendrie M; Creemers MC; Welsing PM; van Riel PL
Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
[TBL] [Abstract][Full Text] [Related]
15. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
Minami M; Kaneda K
Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
[TBL] [Abstract][Full Text] [Related]
16. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group.
Terkeltaub R; Esdaile J; Décary F; Tannenbaum H
J Rheumatol; 1983 Jun; 10(3):418-24. PubMed ID: 6411919
[TBL] [Abstract][Full Text] [Related]
17. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
Munthe E; Kåss E
J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
[TBL] [Abstract][Full Text] [Related]
18. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
Mariani L; Baratelli M
Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749
[No Abstract] [Full Text] [Related]
19. D-penicillamine-induced increase in intracellular glutathione correlating to clinical response in rheumatoid arthritis.
Munthe E; Kåss E; Jellum E
J Rheumatol Suppl; 1981; 7():14-9. PubMed ID: 6785436
[TBL] [Abstract][Full Text] [Related]
20. [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression].
Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
Ter Arkh; 1982; 54(6):82-92. PubMed ID: 7112429
[No Abstract] [Full Text] [Related]
[Next] [New Search]
